 |
Comparison
of gliclazide with insulin as initial treatment modality in newly
diagnosed type 2 diabetes |
| |
Comparable glycemic control could be achieved
with both insulin and oral hypoglycemic agent in newly diagnosed
type 2 diabetes subjects. Insulin treatment exceeded gliclazide
in the remission (drug-free) rate (PubMed) |
| |
|
|
Absence
of an acute insulin response predicts onset of type 2 diabetes |
| |
In these Caucasian persons with IGT, the absence
of the first insulin peak was the strongest predictor of T2DM (PubMed) |
| |
|
|
From
the bench to the bedside: dipeptidyl peptidase IV inhibitors,
a new class of oral antihyperglycemic agents |
| |
This article provides an overview of the recent
advances in and the lessons learned from the design of potent and
selective small-molecule inhibitors of DPP-IV for the treatment
of type 2 diabetes (PubMed) |
| |
|
